Alendronic Acid News
Alendronic Acid currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Alendronic Acid with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Treatment of postmenopausal osteoporosis in patients at risk of vitamin-D insufficiency. Fosavance reduces the risk of vertebral and hip fractures.
- Evidence level: L5
- Predicted indications (20):
- bone Paget disease (99.3%)
- HIV infectious disease (96.8%)
- neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter (95.2%)
- simian immunodeficiency virus infection (94.8%)
- feline acquired immunodeficiency syndrome (94.8%)
- deficiency anemia (94.2%)
- juvenile Paget disease (93.3%)
- vitamin B12- and folate-independent constitutional megaloblastic anemia (90.6%)
- Plummer-Vinson syndrome (90.4%)
- osteomesopyknosis (88.2%)
- obsolete familial combined hyperlipidemia (86.3%)
- biotin metabolic disease (86.2%)
- Paget disease of bone (85.5%)
- primary release disorder of platelets (84.7%)
- pseudo-von Willebrand disease (84.3%)
- Paget disease of bone 2, early-onset (81.9%)
- penile fibromatosis (80.0%)
- vitamin deficiency disorder (78.2%)
- palmar fibromatosis (77.5%)
- infantile digital fibromatosis (76.3%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.